Get startedLog in
    Picture of Annexin Pharmaceuticals AB (publ) logo

    ANNX — Annexin Pharmaceuticals AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: University Hospital Gets Approval For Covid19-Study With Annexin Drug Candidate

    Picture of Annexin Pharmaceuticals AB (publ) logoAnnexin Pharmaceuticals AB (publ)
    19/01/2022 10:48
    Jan 19 (Reuters) - Annexin Pharmaceuticals AB (publ)
 ANNX.ST :
    * APPROVAL OF COVID19-STUDY
    * MAASTRICHT UNIVERSITY HOSPITAL RECEIVES APPROVALS TO START
STUDY
WITH ANNEXIN PHARMACEUTICALS DRUG CANDIDATE, ANXV
    * WILL CONTRIBUTE ANXV, LIMITED PATIENT-RELATED COSTS AND
DRUG-SPECIFIC DOCUMENTATION AND ANALYSES.

Source text for Eikon:  ID:nWkr8GqTC1 
Further company coverage:  ANNX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Annexin Pharmaceuticals AB (publ)

    See all news